#ISSjD2026
💉Sjogren’s in the New Therapeutic Era: Translating Recent Clinical Trials into Practice
👤Thomas GRADER-BECK
Positive late-stage clinical trials:
#Ianalumab (NEPTUNUS-1/2, n=779)
#Telitacicept (n=381)
Primary endpoint: change in ESSDAI
#sjogren
💉Sjogren’s in the New Therapeutic Era: Translating Recent Clinical Trials into Practice
👤Thomas GRADER-BECK
Positive late-stage clinical trials:
#Ianalumab (NEPTUNUS-1/2, n=779)
#Telitacicept (n=381)
Primary endpoint: change in ESSDAI
#sjogren